Pembrolizumab
14 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Sitravatinib Plus Pembrolizumab in Patients With Advanced Treatment-Naïve PD-L1+ Non-Squamous NSCLC (NCT04925986) | Sarah Goldberg | 2022-02-10 |
| Pembrolizumab and Lenvatinib in Patients With Brain Metastases From Melanoma or Renal Cell Carcinoma (NCT04955743) | Yale University | 2022-02-09 |
| Pembrolizumab in Post Radical Operation ESCC Patients With Lymph Node Positive ( KEYSTONE-004 ) (NCT04863079) | Tianjin Medical University Cancer Institute and Hospital | 2021-05-01 |
| Pembrolizumab Plus Neoadjuvant Chemotherapy for Locally Advanced EGJ Adenocarcinoma (NCT04813523) | Tianjin Medical University Cancer Institute and Hospital | 2021-04-01 |
| A Study With Pembrolizumab for Non-small Cell Lung Cancer (NSCLC) (NCT04393883) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2021-04-01 |
| Analysis of Gut Microbiota in Patients With Brain Metastasis of Non-small Cell Lung Cancer Treated by Pembrolizumab Combined With Chemotherapy (NCT04333004) | Xiaorong Dong | 2020-04-01 |
Track Pembrolizumab automatically
Every clearance here is in the API, with alerts when new ones post.